17.07.2014 • NewsDede WillamsLuciano RossettiMerck

Luciano Rossetti Moves from Merck to Merck

Merck Serono, the biopharmaceutical division of Germany's Merck KGaA has appointed Luciano Rossetti as executive vice president and global head of research & development with effect from July 2.

Rossetti most recently was Senior Vice President Late Stage Development at US pharmaceutical producer Merck Sharp & Dohme, where he was responsible for the entire clinical development from Phase II to Phase V across all therapeutic areas.

The new R&D chief will be based in Billerica, outside Boston, Massachusetts, in the US, one of Merck Serono's four global R&D hubs, and will share his time between Merck's headquarters in Darmstadt, Germany, and Billerica.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Virtual Event

DIGITALIZATION IN THE CHEMICAL INDUSTRY

DIGITALIZATION IN THE CHEMICAL INDUSTRY

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.